Strength Cancer Research Results

Strength, physical strength: Click to Expand ⟱
Source:
Type:
Physical strength


Stroke, Cerebral Ischemic Stroke: Click to Expand ⟱
Ischemic stroke is also called brain ischemia and cerebral ischemia. Ischemia is the medical term for "lack of blood supply."


Scientific Papers found: Click to Expand⟱
3319- SIL,    Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms
- Review, AD, NA - Review, Park, NA - Review, Stroke, NA
*neuroP↑, *ROS↓, *Inflam↓, *Apoptosis↓, *BBB?, *tau↓, *NF-kB↓, *IL1β↓, *TNF-α↓, *IL4↓, *MAPK↓, *memory↑, *cognitive↑, *Aβ↓, *ROS↓, *lipid-P↓, *GSH↑, *MDA↓, *SOD↑, *Catalase↑, *AChE↓, *BChE↓, *p‑ERK↓, *p‑JNK↓, *p‑p38↓, *GutMicro↑, *COX2↓, *iNOS↓, *TLR4↓, *neuroP↑, *Strength↑, *AMPK↑, *MMP↑, *necrosis↓, *NRF2↑, *HO-1↑,
4869- Uro,    Urolithin A in Central Nervous System Disorders: Therapeutic Applications and Challenges
- Review, AD, NA - Review, Park, NA - Review, Stroke, NA
*MitoP↑, *Inflam↓, *antiOx↑, *Risk↓, *Aβ↓, *p‑tau↓, *p62↓, *PARK2↑, *MMP↑, *ROS↓, *Strength↑, *CRP↓, *IL1β↓, *IL6↓, *TNF-α↓, *AMPK↑, *NF-kB↓, *MAPK↓, *p62↑, *NRF2↑, *SOD↑, *Catalase↑, *HO-1↑, *Ferroptosis↓, *lipid-P↓, *Cartilage↑, *PI3K↓, *Akt↓, *mTOR↓, *Apoptosis↓, *neuroP↑, *Bcl-2↓, *BAX↑, *Casp3↑, *ATP↑, *eff↑, *motorD↑, *NLRP3↓, *radioP↑, *BBB↑,
4875- Uro,    Impact of the Natural Compound Urolithin A on Health, Disease, and Aging
- Review, AD, NA - Review, Stroke, NA - Review, ostP, NA - Review, IBD, NA
*MitoP↓, *Strength↑, *PINK1↑, *PARK2↑, *Inflam↓, *COX2↓, *IL1β↓, *IL6↓, *TNF-α↓, *OS↑, *cardioP↑, *memory↑, *neuroG↑, *neuroP↑, *Cartilage↑, *Inflam↓, *RenoP↑, *eff↑, *Dose↝, *Half-Life↑, *NRF2↑, *GutMicro↑,

Showing Research Papers: 1 to 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


Total Targets: 0

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx↑, 1,   Catalase↑, 2,   Ferroptosis↓, 1,   GSH↑, 1,   HO-1↑, 2,   lipid-P↓, 2,   MDA↓, 1,   NRF2↑, 3,   PARK2↑, 2,   ROS↓, 3,   SOD↑, 2,  

Mitochondria & Bioenergetics

ATP↑, 1,   MMP↑, 2,   PINK1↑, 1,  

Core Metabolism/Glycolysis

AMPK↑, 2,  

Cell Death

Akt↓, 1,   Apoptosis↓, 2,   BAX↑, 1,   Bcl-2↓, 1,   Casp3↑, 1,   Ferroptosis↓, 1,   iNOS↓, 1,   p‑JNK↓, 1,   MAPK↓, 2,   necrosis↓, 1,   p‑p38↓, 1,  

Autophagy & Lysosomes

MitoP↓, 1,   MitoP↑, 1,   p62↓, 1,   p62↑, 1,  

Proliferation, Differentiation & Cell State

p‑ERK↓, 1,   mTOR↓, 1,   neuroG↑, 1,   PI3K↓, 1,  

Migration

Cartilage↑, 2,  

Barriers & Transport

BBB?, 1,   BBB↑, 1,  

Immune & Inflammatory Signaling

COX2↓, 2,   CRP↓, 1,   IL1β↓, 3,   IL4↓, 1,   IL6↓, 2,   Inflam↓, 4,   NF-kB↓, 2,   TLR4↓, 1,   TNF-α↓, 3,  

Synaptic & Neurotransmission

AChE↓, 1,   BChE↓, 1,   tau↓, 1,   p‑tau↓, 1,  

Protein Aggregation

Aβ↓, 2,   NLRP3↓, 1,  

Drug Metabolism & Resistance

Dose↝, 1,   eff↑, 2,   Half-Life↑, 1,  

Clinical Biomarkers

CRP↓, 1,   GutMicro↑, 2,   IL6↓, 2,  

Functional Outcomes

cardioP↑, 1,   cognitive↑, 1,   memory↑, 2,   motorD↑, 1,   neuroP↑, 4,   OS↑, 1,   radioP↑, 1,   RenoP↑, 1,   Risk↓, 1,   Strength↑, 3,  
Total Targets: 68

Scientific Paper Hit Count for: Strength, physical strength
2 Urolithin
1 Silymarin (Milk Thistle) silibinin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:36  Cells:%  prod#:%  Target#:578  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page